The thing that strikes me about this is the potential for this to be a disease curing conveyer belt. Find a target organ identify a disease with a single strand mutation and an under expressed protein. Optimise the CPP PMO combination. Run the trials. 62 percent chance of success. I don’t mean to downplay or be flippant about the science I just mean they could already have a large list of targets organised in order of priority. Once revenue is coming in the potential could be enormous. Am I being overly optimistic?
Ann: Polycystic Kidney Disease Program Presentation, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |